

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of glycogen biosynthetic process (GO:0045719) | 5.43618767 |
| 2 | chondroitin sulfate catabolic process (GO:0030207) | 5.31097360 |
| 3 | COPII vesicle coating (GO:0048208) | 5.01319363 |
| 4 | protein K11-linked deubiquitination (GO:0035871) | 4.73079352 |
| 5 | C4-dicarboxylate transport (GO:0015740) | 4.69769428 |
| 6 | regulation of glycogen (starch) synthase activity (GO:2000465) | 4.60068569 |
| 7 | iron ion import (GO:0097286) | 4.42136714 |
| 8 | mannose metabolic process (GO:0006013) | 4.37048621 |
| 9 | cellular response to zinc ion (GO:0071294) | 4.28621431 |
| 10 | seminiferous tubule development (GO:0072520) | 4.28037425 |
| 11 | vitamin transmembrane transport (GO:0035461) | 4.16441592 |
| 12 | vitamin A metabolic process (GO:0006776) | 4.14299762 |
| 13 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 4.01253024 |
| 14 | regulation of energy homeostasis (GO:2000505) | 3.98384797 |
| 15 | response to dietary excess (GO:0002021) | 3.97116373 |
| 16 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.95634128 |
| 17 | negative regulation of glycogen metabolic process (GO:0070874) | 3.90393728 |
| 18 | snRNA transcription (GO:0009301) | 3.84195797 |
| 19 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 3.76812839 |
| 20 | regulation of chromatin binding (GO:0035561) | 3.75492494 |
| 21 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.72522976 |
| 22 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.71509844 |
| 23 | regulation of integrin activation (GO:0033623) | 3.70799528 |
| 24 | regulation of RNA export from nucleus (GO:0046831) | 3.66176774 |
| 25 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.61724643 |
| 26 | melanin biosynthetic process (GO:0042438) | 3.58853151 |
| 27 | protein targeting to Golgi (GO:0000042) | 3.52759252 |
| 28 | melanin metabolic process (GO:0006582) | 3.48816051 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 3.47829367 |
| 30 | motile cilium assembly (GO:0044458) | 3.45961879 |
| 31 | establishment of protein localization to Golgi (GO:0072600) | 3.44530369 |
| 32 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.43428092 |
| 33 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.42086292 |
| 34 | regulation of cholesterol homeostasis (GO:2000188) | 3.33786737 |
| 35 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.30866241 |
| 36 | regulation of gene expression by genetic imprinting (GO:0006349) | 3.30731103 |
| 37 | negative regulation of amino acid transport (GO:0051956) | 3.28931599 |
| 38 | NLS-bearing protein import into nucleus (GO:0006607) | 3.27197333 |
| 39 | genetic imprinting (GO:0071514) | 3.26573950 |
| 40 | inner ear receptor cell differentiation (GO:0060113) | 3.23944189 |
| 41 | negative regulation of catenin import into nucleus (GO:0035414) | 3.19382108 |
| 42 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.18461990 |
| 43 | tyrosine metabolic process (GO:0006570) | 3.11390734 |
| 44 | negative regulation of glucose import (GO:0046325) | 3.11015241 |
| 45 | blood coagulation, intrinsic pathway (GO:0007597) | 3.10878953 |
| 46 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.10242049 |
| 47 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.08857323 |
| 48 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 3.07798255 |
| 49 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 3.07798255 |
| 50 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.07349835 |
| 51 | coenzyme A biosynthetic process (GO:0015937) | 3.06941794 |
| 52 | nuclear pore complex assembly (GO:0051292) | 3.04780507 |
| 53 | membrane tubulation (GO:0097320) | 3.01568663 |
| 54 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.99991805 |
| 55 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.99525382 |
| 56 | activation of Rac GTPase activity (GO:0032863) | 2.96849178 |
| 57 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.96255974 |
| 58 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.96255974 |
| 59 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.96255974 |
| 60 | negative regulation of muscle hypertrophy (GO:0014741) | 2.95673503 |
| 61 | positive regulation of action potential (GO:0045760) | 2.92425068 |
| 62 | regulation of peptidyl-threonine phosphorylation (GO:0010799) | 2.86266332 |
| 63 | drinking behavior (GO:0042756) | 2.83217137 |
| 64 | cellular response to glucagon stimulus (GO:0071377) | 2.83088224 |
| 65 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.82520123 |
| 66 | viral mRNA export from host cell nucleus (GO:0046784) | 2.81693403 |
| 67 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.81436313 |
| 68 | nitric oxide biosynthetic process (GO:0006809) | 2.81223385 |
| 69 | protein localization to Golgi apparatus (GO:0034067) | 2.79664451 |
| 70 | arginine catabolic process (GO:0006527) | 2.78284428 |
| 71 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.77334417 |
| 72 | auditory behavior (GO:0031223) | 2.77068863 |
| 73 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.76442675 |
| 74 | negative regulation of heart growth (GO:0061117) | 2.76442675 |
| 75 | vesicle coating (GO:0006901) | 2.76226275 |
| 76 | negative regulation of glucose transport (GO:0010829) | 2.73118409 |
| 77 | positive regulation of gluconeogenesis (GO:0045722) | 2.72377788 |
| 78 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.71065443 |
| 79 | intestinal cholesterol absorption (GO:0030299) | 2.70433042 |
| 80 | plasma lipoprotein particle assembly (GO:0034377) | 2.68604446 |
| 81 | biotin metabolic process (GO:0006768) | 2.66618517 |
| 82 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.65996286 |
| 83 | oligosaccharide catabolic process (GO:0009313) | 2.64818272 |
| 84 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.64586287 |
| 85 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.64586287 |
| 86 | regulation of protein activation cascade (GO:2000257) | 2.60176562 |
| 87 | regulation of fibrinolysis (GO:0051917) | 2.59419708 |
| 88 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.59127682 |
| 89 | L-phenylalanine catabolic process (GO:0006559) | 2.59127682 |
| 90 | acetyl-CoA metabolic process (GO:0006084) | 2.59057630 |
| 91 | regulation of complement activation (GO:0030449) | 2.57650087 |
| 92 | low-density lipoprotein particle remodeling (GO:0034374) | 2.55888372 |
| 93 | L-glutamate transport (GO:0015813) | 2.55888064 |
| 94 | COPI coating of Golgi vesicle (GO:0048205) | 2.55403862 |
| 95 | Golgi transport vesicle coating (GO:0048200) | 2.55403862 |
| 96 | positive regulation of mRNA 3-end processing (GO:0031442) | 2.54594005 |
| 97 | secondary metabolite biosynthetic process (GO:0044550) | 2.54067260 |
| 98 | regulation of norepinephrine secretion (GO:0014061) | 2.52606991 |
| 99 | regulation of glutamate secretion (GO:0014048) | 2.52378891 |
| 100 | imidazole-containing compound metabolic process (GO:0052803) | 2.51117549 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 6.41316431 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.03666364 |
| 3 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.56766294 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 3.29522254 |
| 5 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.11762530 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.83784550 |
| 7 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.76538797 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.70527891 |
| 9 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.61388683 |
| 10 | GATA1_19941826_ChIP-Seq_K562_Human | 2.60655486 |
| 11 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.55958315 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.45356664 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.31498904 |
| 14 | NCOR1_26117541_ChIP-Seq_K562_Human | 2.31481510 |
| 15 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.24246514 |
| 16 | GATA2_19941826_ChIP-Seq_K562_Human | 2.11428576 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.07902722 |
| 18 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.97768323 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.97572240 |
| 20 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.96109385 |
| 21 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.94271906 |
| 22 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.91361174 |
| 23 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.79855459 |
| 24 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.77773069 |
| 25 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.76668118 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.73611039 |
| 27 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.69339452 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.66242735 |
| 29 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.55814019 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52914908 |
| 31 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.51327473 |
| 32 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.50823101 |
| 33 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.43697471 |
| 34 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.43109860 |
| 35 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.40338214 |
| 36 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.39546059 |
| 37 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37691418 |
| 38 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.34653020 |
| 39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.34468105 |
| 40 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.34061533 |
| 41 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32475915 |
| 42 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.31461146 |
| 43 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.28997572 |
| 44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.28920828 |
| 45 | JUN_21703547_ChIP-Seq_K562_Human | 1.27839836 |
| 46 | P68_20966046_ChIP-Seq_HELA_Human | 1.27725361 |
| 47 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.26597422 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.23658472 |
| 49 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23388690 |
| 50 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23263943 |
| 51 | KDM2B_26808549_Chip-Seq_K562_Human | 1.21745525 |
| 52 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.21500725 |
| 53 | MAF_26560356_Chip-Seq_TH1_Human | 1.21477761 |
| 54 | MYC_22102868_ChIP-Seq_BL_Human | 1.19950471 |
| 55 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.19746424 |
| 56 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.19349125 |
| 57 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.18989195 |
| 58 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.17862221 |
| 59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17804651 |
| 60 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.17171760 |
| 61 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.15689428 |
| 62 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14959491 |
| 63 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.14528498 |
| 64 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.14172241 |
| 65 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.13806870 |
| 66 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.11732427 |
| 67 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.11091403 |
| 68 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.10697330 |
| 69 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.09974347 |
| 70 | P300_27268052_Chip-Seq_Bcells_Human | 1.09837016 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08853595 |
| 72 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.08127366 |
| 73 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.08111480 |
| 74 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.07580967 |
| 75 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.05699397 |
| 76 | TP53_16413492_ChIP-PET_HCT116_Human | 1.05116548 |
| 77 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.04969818 |
| 78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02554754 |
| 79 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.02307728 |
| 80 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.01805610 |
| 81 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.01096067 |
| 82 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.01031553 |
| 83 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00581552 |
| 84 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00035112 |
| 85 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.99682190 |
| 86 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.98425675 |
| 87 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98374101 |
| 88 | UTX_26944678_Chip-Seq_JUKART_Human | 0.98143818 |
| 89 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.98097331 |
| 90 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.97409172 |
| 91 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94480171 |
| 92 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.94257223 |
| 93 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93305373 |
| 94 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93094653 |
| 95 | STAT3_23295773_ChIP-Seq_U87_Human | 0.92565929 |
| 96 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92103480 |
| 97 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.91791515 |
| 98 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.91681782 |
| 99 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.90231129 |
| 100 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.89202894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005171_absent_coat_pigmentation | 3.90487486 |
| 2 | MP0004233_abnormal_muscle_weight | 3.74031753 |
| 3 | MP0005408_hypopigmentation | 3.60361094 |
| 4 | MP0003136_yellow_coat_color | 3.48803813 |
| 5 | MP0005083_abnormal_biliary_tract | 3.11273250 |
| 6 | MP0002909_abnormal_adrenal_gland | 2.77359702 |
| 7 | MP0003950_abnormal_plasma_membrane | 2.66848721 |
| 8 | MP0005451_abnormal_body_composition | 2.65309062 |
| 9 | MP0005360_urolithiasis | 2.52106281 |
| 10 | MP0005257_abnormal_intraocular_pressure | 2.50741725 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.48266621 |
| 12 | MP0003172_abnormal_lysosome_physiology | 2.28272082 |
| 13 | MP0004264_abnormal_extraembryonic_tissu | 2.25483120 |
| 14 | MP0000372_irregular_coat_pigmentation | 2.21061899 |
| 15 | MP0004185_abnormal_adipocyte_glucose | 1.98388023 |
| 16 | MP0000678_abnormal_parathyroid_gland | 1.96156058 |
| 17 | MP0005167_abnormal_blood-brain_barrier | 1.94278045 |
| 18 | MP0010329_abnormal_lipoprotein_level | 1.91532375 |
| 19 | MP0003011_delayed_dark_adaptation | 1.88355858 |
| 20 | MP0003656_abnormal_erythrocyte_physiolo | 1.86007123 |
| 21 | MP0003959_abnormal_lean_body | 1.84802912 |
| 22 | MP0003045_fibrosis | 1.83212792 |
| 23 | MP0003123_paternal_imprinting | 1.76452442 |
| 24 | MP0004510_myositis | 1.74786871 |
| 25 | MP0005058_abnormal_lysosome_morphology | 1.71337000 |
| 26 | MP0004381_abnormal_hair_follicle | 1.68882534 |
| 27 | MP0000609_abnormal_liver_physiology | 1.66533489 |
| 28 | MP0002009_preneoplasia | 1.65868133 |
| 29 | MP0003646_muscle_fatigue | 1.55065582 |
| 30 | MP0005409_darkened_coat_color | 1.54486256 |
| 31 | MP0003252_abnormal_bile_duct | 1.52756366 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.52187811 |
| 33 | MP0000371_diluted_coat_color | 1.49506879 |
| 34 | MP0003868_abnormal_feces_composition | 1.45333956 |
| 35 | MP0005365_abnormal_bile_salt | 1.42465309 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 1.39292874 |
| 37 | MP0009697_abnormal_copulation | 1.35607689 |
| 38 | MP0008875_abnormal_xenobiotic_pharmacok | 1.34538582 |
| 39 | MP0003942_abnormal_urinary_system | 1.34412510 |
| 40 | MP0002089_abnormal_postnatal_growth/wei | 1.34336584 |
| 41 | MP0005551_abnormal_eye_electrophysiolog | 1.29290460 |
| 42 | MP0001919_abnormal_reproductive_system | 1.28048126 |
| 43 | MP0009046_muscle_twitch | 1.22386088 |
| 44 | MP0002075_abnormal_coat/hair_pigmentati | 1.16933321 |
| 45 | MP0004742_abnormal_vestibular_system | 1.14676104 |
| 46 | MP0003698_abnormal_male_reproductive | 1.08180844 |
| 47 | MP0002078_abnormal_glucose_homeostasis | 1.07438730 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.05642756 |
| 49 | MP0005085_abnormal_gallbladder_physiolo | 1.02240085 |
| 50 | MP0008961_abnormal_basal_metabolism | 1.00954632 |
| 51 | MP0003953_abnormal_hormone_level | 1.00782285 |
| 52 | MP0001727_abnormal_embryo_implantation | 1.00270187 |
| 53 | MP0001765_abnormal_ion_homeostasis | 0.98894818 |
| 54 | MP0005187_abnormal_penis_morphology | 0.98549298 |
| 55 | MP0003111_abnormal_nucleus_morphology | 0.97999184 |
| 56 | MP0001661_extended_life_span | 0.96964765 |
| 57 | MP0001186_pigmentation_phenotype | 0.96633582 |
| 58 | MP0003879_abnormal_hair_cell | 0.94879522 |
| 59 | MP0004130_abnormal_muscle_cell | 0.94744464 |
| 60 | MP0003638_abnormal_response/metabolism_ | 0.94426795 |
| 61 | MP0003122_maternal_imprinting | 0.92360568 |
| 62 | MP0002118_abnormal_lipid_homeostasis | 0.91204884 |
| 63 | MP0010094_abnormal_chromosome_stability | 0.88530454 |
| 64 | MP0002210_abnormal_sex_determination | 0.88244544 |
| 65 | MP0003699_abnormal_female_reproductive | 0.87910917 |
| 66 | MP0005253_abnormal_eye_physiology | 0.87516648 |
| 67 | MP0005636_abnormal_mineral_homeostasis | 0.86766669 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 0.86378959 |
| 69 | MP0005448_abnormal_energy_balance | 0.85735561 |
| 70 | MP0005645_abnormal_hypothalamus_physiol | 0.85548294 |
| 71 | MP0000639_abnormal_adrenal_gland | 0.84093611 |
| 72 | MP0002229_neurodegeneration | 0.83978182 |
| 73 | MP0002095_abnormal_skin_pigmentation | 0.83784871 |
| 74 | MP0002168_other_aberrant_phenotype | 0.83042763 |
| 75 | MP0005220_abnormal_exocrine_pancreas | 0.82271677 |
| 76 | MP0005647_abnormal_sex_gland | 0.81687689 |
| 77 | MP0008569_lethality_at_weaning | 0.81631580 |
| 78 | MP0005389_reproductive_system_phenotype | 0.81433234 |
| 79 | MP0008770_decreased_survivor_rate | 0.80579873 |
| 80 | MP0000598_abnormal_liver_morphology | 0.80320857 |
| 81 | MP0001666_abnormal_nutrient_absorption | 0.79713867 |
| 82 | MP0002269_muscular_atrophy | 0.78916013 |
| 83 | MP0005075_abnormal_melanosome_morpholog | 0.78555878 |
| 84 | MP0001929_abnormal_gametogenesis | 0.77813770 |
| 85 | MP0004134_abnormal_chest_morphology | 0.77730596 |
| 86 | MP0002970_abnormal_white_adipose | 0.76431128 |
| 87 | MP0000653_abnormal_sex_gland | 0.75987691 |
| 88 | MP0001915_intracranial_hemorrhage | 0.73666702 |
| 89 | MP0004142_abnormal_muscle_tone | 0.73161236 |
| 90 | MP0002396_abnormal_hematopoietic_system | 0.72994639 |
| 91 | MP0008007_abnormal_cellular_replicative | 0.72893718 |
| 92 | MP0008775_abnormal_heart_ventricle | 0.70488601 |
| 93 | MP0000015_abnormal_ear_pigmentation | 0.70393980 |
| 94 | MP0005310_abnormal_salivary_gland | 0.69809010 |
| 95 | MP0001145_abnormal_male_reproductive | 0.69009580 |
| 96 | MP0009642_abnormal_blood_homeostasis | 0.69008825 |
| 97 | MP0002877_abnormal_melanocyte_morpholog | 0.66807061 |
| 98 | MP0004085_abnormal_heartbeat | 0.64539562 |
| 99 | MP0002557_abnormal_social/conspecific_i | 0.62974325 |
| 100 | MP0002653_abnormal_ependyma_morphology | 0.61418493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Macroorchidism (HP:0000053) | 5.42553004 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.90743609 |
| 3 | Abnormal gallbladder physiology (HP:0012438) | 4.67559143 |
| 4 | Cholecystitis (HP:0001082) | 4.67559143 |
| 5 | Dysmetric saccades (HP:0000641) | 4.40829650 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 3.94433006 |
| 7 | Menorrhagia (HP:0000132) | 3.76357311 |
| 8 | Abnormality of glycolysis (HP:0004366) | 3.66274650 |
| 9 | Increased serum pyruvate (HP:0003542) | 3.61833671 |
| 10 | Spontaneous abortion (HP:0005268) | 3.57484840 |
| 11 | Polycythemia (HP:0001901) | 3.52709424 |
| 12 | Hyperthyroidism (HP:0000836) | 3.41432545 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 3.39451765 |
| 14 | Hyperacusis (HP:0010780) | 3.12205682 |
| 15 | Absent/shortened dynein arms (HP:0200106) | 3.11778476 |
| 16 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.11778476 |
| 17 | Prolonged partial thromboplastin time (HP:0003645) | 3.11576941 |
| 18 | Reticulocytosis (HP:0001923) | 3.05583508 |
| 19 | Truncus arteriosus (HP:0001660) | 3.04541863 |
| 20 | Urethral obstruction (HP:0000796) | 3.03971432 |
| 21 | Prolonged bleeding time (HP:0003010) | 2.94691287 |
| 22 | Tubulointerstitial nephritis (HP:0001970) | 2.89359773 |
| 23 | Nonimmune hydrops fetalis (HP:0001790) | 2.89355255 |
| 24 | Abnormality of DNA repair (HP:0003254) | 2.84256033 |
| 25 | Peritonitis (HP:0002586) | 2.71304743 |
| 26 | Bowel incontinence (HP:0002607) | 2.65949254 |
| 27 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.65738374 |
| 28 | Acanthocytosis (HP:0001927) | 2.65517243 |
| 29 | Heterotopia (HP:0002282) | 2.62936466 |
| 30 | Submucous cleft hard palate (HP:0000176) | 2.60003520 |
| 31 | Impaired pain sensation (HP:0007328) | 2.57421737 |
| 32 | Abnormality of pain sensation (HP:0010832) | 2.57421737 |
| 33 | Abnormal large intestine physiology (HP:0012700) | 2.48161425 |
| 34 | Morphological abnormality of the middle ear (HP:0008609) | 2.43836404 |
| 35 | Genetic anticipation (HP:0003743) | 2.42348445 |
| 36 | Dyschromatopsia (HP:0007641) | 2.40866892 |
| 37 | Sparse lateral eyebrow (HP:0005338) | 2.39845546 |
| 38 | Poikilocytosis (HP:0004447) | 2.29149046 |
| 39 | Hyperphosphatemia (HP:0002905) | 2.25996877 |
| 40 | Abnormality of the fingertips (HP:0001211) | 2.24600830 |
| 41 | Abnormality of the tricuspid valve (HP:0001702) | 2.23542852 |
| 42 | Entropion (HP:0000621) | 2.22328096 |
| 43 | Wide intermamillary distance (HP:0006610) | 2.14832494 |
| 44 | Joint hemorrhage (HP:0005261) | 2.14806175 |
| 45 | Subacute progressive viral hepatitis (HP:0006572) | 2.14337134 |
| 46 | Spinal cord lesions (HP:0100561) | 2.10461246 |
| 47 | Syringomyelia (HP:0003396) | 2.10461246 |
| 48 | Concave nail (HP:0001598) | 2.09047110 |
| 49 | Microvesicular hepatic steatosis (HP:0001414) | 2.07945478 |
| 50 | Abnormality of the aortic arch (HP:0012303) | 2.07019027 |
| 51 | Increased number of teeth (HP:0011069) | 2.07008024 |
| 52 | Cholelithiasis (HP:0001081) | 2.06925527 |
| 53 | Broad palm (HP:0001169) | 2.06718928 |
| 54 | Blue irides (HP:0000635) | 2.04964300 |
| 55 | Abnormal ciliary motility (HP:0012262) | 2.02284728 |
| 56 | Broad face (HP:0000283) | 2.01056502 |
| 57 | Enlarged penis (HP:0000040) | 1.99288043 |
| 58 | Fat malabsorption (HP:0002630) | 1.99249693 |
| 59 | Myocardial infarction (HP:0001658) | 1.98942949 |
| 60 | Seborrheic dermatitis (HP:0001051) | 1.96336868 |
| 61 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.95858363 |
| 62 | Hypolipoproteinemia (HP:0010981) | 1.95026597 |
| 63 | Xanthomatosis (HP:0000991) | 1.94331140 |
| 64 | Generalized aminoaciduria (HP:0002909) | 1.94282193 |
| 65 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.91857138 |
| 66 | Menstrual irregularities (HP:0000858) | 1.90952559 |
| 67 | Hyperkalemia (HP:0002153) | 1.90037697 |
| 68 | Attention deficit hyperactivity disorder (HP:0007018) | 1.89365763 |
| 69 | Severe visual impairment (HP:0001141) | 1.87521603 |
| 70 | Spastic paraparesis (HP:0002313) | 1.85316999 |
| 71 | Sensorimotor neuropathy (HP:0007141) | 1.84628721 |
| 72 | Midline defect of the nose (HP:0004122) | 1.83691838 |
| 73 | Disproportionate tall stature (HP:0001519) | 1.83577842 |
| 74 | Renovascular hypertension (HP:0100817) | 1.81705591 |
| 75 | Poikiloderma (HP:0001029) | 1.81612963 |
| 76 | Termporal pattern (HP:0011008) | 1.81076127 |
| 77 | Insidious onset (HP:0003587) | 1.81076127 |
| 78 | Hypercholesterolemia (HP:0003124) | 1.78880072 |
| 79 | Portal hypertension (HP:0001409) | 1.76179180 |
| 80 | Abnormality of reticulocytes (HP:0004312) | 1.75870934 |
| 81 | Underdeveloped nasal alae (HP:0000430) | 1.75518202 |
| 82 | Esophageal varix (HP:0002040) | 1.73906225 |
| 83 | Hypopigmentation of the fundus (HP:0007894) | 1.73577971 |
| 84 | Coarse hair (HP:0002208) | 1.73465153 |
| 85 | Hypergonadotropic hypogonadism (HP:0000815) | 1.72751141 |
| 86 | Hepatocellular carcinoma (HP:0001402) | 1.72156041 |
| 87 | Abnormality of the columella (HP:0009929) | 1.70940973 |
| 88 | Short chin (HP:0000331) | 1.70196574 |
| 89 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.69071795 |
| 90 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.69071795 |
| 91 | Flat cornea (HP:0007720) | 1.68781898 |
| 92 | Vascular calcification (HP:0004934) | 1.68154039 |
| 93 | Thin bony cortex (HP:0002753) | 1.67717410 |
| 94 | Impaired platelet aggregation (HP:0003540) | 1.67668079 |
| 95 | Abnormal platelet function (HP:0011869) | 1.67668079 |
| 96 | Amelogenesis imperfecta (HP:0000705) | 1.67665333 |
| 97 | Narrow palate (HP:0000189) | 1.67330908 |
| 98 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.66286531 |
| 99 | Gingival bleeding (HP:0000225) | 1.66025458 |
| 100 | Abnormality of the diencephalon (HP:0010662) | 1.65518385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 3.82627671 |
| 2 | CDK12 | 3.79313499 |
| 3 | ICK | 3.12518234 |
| 4 | SGK3 | 3.05261370 |
| 5 | TRIB3 | 2.88753029 |
| 6 | IRAK2 | 2.86198770 |
| 7 | EEF2K | 2.85169654 |
| 8 | BMPR2 | 2.57268271 |
| 9 | SCYL2 | 2.52287497 |
| 10 | CAMK1D | 2.52257533 |
| 11 | AKT3 | 2.40365443 |
| 12 | CAMK1G | 2.38866135 |
| 13 | PRKCH | 2.18105972 |
| 14 | EIF2AK1 | 2.00266674 |
| 15 | CLK1 | 1.93531109 |
| 16 | RIPK4 | 1.81567661 |
| 17 | FGFR4 | 1.65931172 |
| 18 | PDK2 | 1.63222913 |
| 19 | NEK9 | 1.47715576 |
| 20 | FGFR3 | 1.45306330 |
| 21 | SMG1 | 1.41085792 |
| 22 | SGK494 | 1.34461428 |
| 23 | SGK223 | 1.34461428 |
| 24 | CAMKK2 | 1.32837378 |
| 25 | WNK4 | 1.31850334 |
| 26 | TYRO3 | 1.29253794 |
| 27 | MKNK2 | 1.29071010 |
| 28 | PRKAA2 | 1.27393329 |
| 29 | SGK1 | 1.23243312 |
| 30 | MAP3K4 | 1.22534163 |
| 31 | MAP2K7 | 1.22362152 |
| 32 | NEK1 | 1.21924524 |
| 33 | PKN2 | 1.20105505 |
| 34 | RIPK1 | 1.19885843 |
| 35 | MTOR | 1.16798501 |
| 36 | MAP3K7 | 1.09324330 |
| 37 | WNK1 | 1.06007090 |
| 38 | SGK2 | 1.04086348 |
| 39 | MAPK11 | 1.02506091 |
| 40 | SIK1 | 0.94285959 |
| 41 | ZAP70 | 0.93824620 |
| 42 | MAP3K2 | 0.91414146 |
| 43 | GSK3A | 0.89397509 |
| 44 | MAPK15 | 0.89085622 |
| 45 | PRKD3 | 0.86304626 |
| 46 | BRD4 | 0.86026037 |
| 47 | PRKAA1 | 0.82481989 |
| 48 | MAP2K4 | 0.79904083 |
| 49 | RET | 0.73986257 |
| 50 | MAPKAPK3 | 0.73772686 |
| 51 | MAP3K13 | 0.70415897 |
| 52 | BTK | 0.67329389 |
| 53 | STK38 | 0.67294021 |
| 54 | PDGFRA | 0.66917520 |
| 55 | DDR2 | 0.65890803 |
| 56 | MAPKAPK5 | 0.64200040 |
| 57 | MAP4K1 | 0.62458492 |
| 58 | EPHA3 | 0.62406229 |
| 59 | CDK9 | 0.59395058 |
| 60 | RPS6KA2 | 0.57446433 |
| 61 | RPS6KL1 | 0.56784569 |
| 62 | RPS6KC1 | 0.56784569 |
| 63 | PRKCB | 0.54166366 |
| 64 | MAPKAPK2 | 0.52241066 |
| 65 | ERBB2 | 0.50616733 |
| 66 | ERBB4 | 0.50069055 |
| 67 | TESK2 | 0.49876576 |
| 68 | PDGFRB | 0.49610584 |
| 69 | IRAK3 | 0.49067720 |
| 70 | FGFR1 | 0.48051248 |
| 71 | MAPK12 | 0.47631380 |
| 72 | RPS6KA6 | 0.47556854 |
| 73 | TRPM7 | 0.47067895 |
| 74 | CDK1 | 0.45750572 |
| 75 | BMX | 0.45465824 |
| 76 | NME2 | 0.44862760 |
| 77 | RPS6KA3 | 0.44051684 |
| 78 | MAPK3 | 0.42012970 |
| 79 | EPHB1 | 0.41278196 |
| 80 | CDK8 | 0.41191030 |
| 81 | CDK7 | 0.41036550 |
| 82 | KSR2 | 0.40880183 |
| 83 | TNIK | 0.40018181 |
| 84 | LATS2 | 0.39767723 |
| 85 | AKT1 | 0.39707119 |
| 86 | MAP3K3 | 0.39333339 |
| 87 | ATM | 0.39329418 |
| 88 | PDPK1 | 0.38886615 |
| 89 | CSNK1E | 0.38849440 |
| 90 | MKNK1 | 0.38044896 |
| 91 | CHUK | 0.37224185 |
| 92 | PDK1 | 0.35355018 |
| 93 | CSNK1A1 | 0.35342323 |
| 94 | NEK6 | 0.34656463 |
| 95 | CAMKK1 | 0.34498939 |
| 96 | TESK1 | 0.34339202 |
| 97 | PRKCG | 0.34169248 |
| 98 | CHEK2 | 0.33794402 |
| 99 | SIK2 | 0.33442223 |
| 100 | MAPK8 | 0.33296370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 5.51915408 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.88900886 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.78691658 |
| 4 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.75446606 |
| 5 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.64017068 |
| 6 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.55280605 |
| 7 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.54702112 |
| 8 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.47025249 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14375292 |
| 10 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.05267751 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.03261647 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.82509642 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.80951283 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.67571968 |
| 15 | Lysine degradation_Homo sapiens_hsa00310 | 1.62805957 |
| 16 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.59133346 |
| 17 | ABC transporters_Homo sapiens_hsa02010 | 1.53335664 |
| 18 | GABAergic synapse_Homo sapiens_hsa04727 | 1.50453471 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.49350501 |
| 20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.34331302 |
| 21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.34287082 |
| 22 | Morphine addiction_Homo sapiens_hsa05032 | 1.28047615 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.22787958 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.22754600 |
| 25 | Mineral absorption_Homo sapiens_hsa04978 | 1.15342278 |
| 26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.08185530 |
| 27 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.06111038 |
| 28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.01726100 |
| 29 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.00272742 |
| 30 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.00093421 |
| 31 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.95701562 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.95640940 |
| 33 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.95620316 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 0.94666837 |
| 35 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.93647451 |
| 36 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.93490154 |
| 37 | Taste transduction_Homo sapiens_hsa04742 | 0.92159895 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.89650882 |
| 39 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.88870534 |
| 40 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.88617424 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85264053 |
| 42 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.85197271 |
| 43 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.85193129 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84781220 |
| 45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84603211 |
| 46 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.84413581 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83108749 |
| 48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.82673586 |
| 49 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81933440 |
| 50 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80921884 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.79750553 |
| 52 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.76721649 |
| 53 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.74554869 |
| 54 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.73511099 |
| 55 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.68660819 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68496709 |
| 57 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68407324 |
| 58 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.67705843 |
| 59 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67349921 |
| 60 | Circadian entrainment_Homo sapiens_hsa04713 | 0.65428915 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.61475174 |
| 62 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60400988 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59950373 |
| 64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58851514 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58615877 |
| 66 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.57421688 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57137719 |
| 68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.56875824 |
| 69 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.56383195 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56011514 |
| 71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.55371716 |
| 72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54857887 |
| 73 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49696958 |
| 74 | Carbon metabolism_Homo sapiens_hsa01200 | 0.47668992 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.47408384 |
| 76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47292385 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47193677 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.46670136 |
| 79 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.44316905 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44125253 |
| 81 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44004723 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43976116 |
| 83 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.43405490 |
| 84 | Phototransduction_Homo sapiens_hsa04744 | 0.43354191 |
| 85 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.40430569 |
| 86 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.39553925 |
| 87 | Glioma_Homo sapiens_hsa05214 | 0.39292651 |
| 88 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39217592 |
| 89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.39185223 |
| 90 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.38803263 |
| 91 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38795439 |
| 92 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.38638439 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37752803 |
| 94 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.37333498 |
| 95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36930700 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.36761212 |
| 97 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.36753197 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35291088 |
| 99 | Alcoholism_Homo sapiens_hsa05034 | 0.33715834 |
| 100 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.32847740 |

